Stay updated with breaking news from Urea Cycle. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
(2022-08-12 | NDAQ:ACER) Relief Therapeutics and Acer Therapeutics Announce that the European Commission Has Granted Orphan Drug Designation for ACER-001 in Maple Syrup Urine Disease
Liver cancer's rapid growth leads to a vulnerability in its energy-production and cell-building processes that may be potently exploited with a new combination-treatment strategy, according to a study from researchers at the Perelman School of Medicine at the University of Pennsylvania.
VS-01 Reduced Plasma Metabolites Associated with Organ Failures Related to ACLF Metabolomic analysis of organ failure markers abstract selected for inclusion in the 'Best of International
At The Bridge Gallery, clay assumes various forms: a colorful slice of cake, a fox lounging on an armchair, sunflower brooches.
Relief Therapeutics Holding SA / Key word(s): Study results Acer Therapeutics and Relief Therapeutics Announce Presentation of ACER-001 Data at the Genetic Metabolic Dieticians International Conference